Cluster Infection Caused by a Terbinafine-resistant Dermatophyte at a Group Home: The First Case Series in Japan
DOI:
https://doi.org/10.2340/00015555-3926Keywords:
antifungal-resistance, efinaconazole, fosravuconazole, itraconazole, squalene epoxidase, terbinafine, Trichophyton rubrumAbstract
Abstract is missing (Short communication)
Downloads
References
Yamada T, Maeda M, Alshahni MM, Tanaka R, Yaguchi T, Bontems O, et al. Terbinafine resistance of Trichophyton clinical isolates caused by specific point mutations in the squalene epoxidase gene. Antimicrob Agents Chemother 2017; 61: e00115–e00117.
Noguchi H, Matsumoto T, Hiruma M, Kimura U, Kano R, Yaguchi T, et al. Tinea unguium caused by terbinafine-resistant Trichophyton rubrum successfully treated with fosravuconazole. J Dermatol 2019; 46: e446–e447.
Hiruma J, Noguchi H, Hase M, Tokuhisa Y, Shimizu T, Ogawa T, et al. Epidemiological study of terbinafine-resistant dermatophytes isolated from Japanese patients. J Dermatol 2021; 48: 564–567.
Itoi S, Kano R, Hasegawa A, Hasegawa A, Kamata H. In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals. J Vet Med Sci 2012; 74: 1067–1069.
Digby SS, Hald M, Arendrup MC, Hjort SV, Kofoed K. Darier disease complicated by terbinafine-resistant Trichophyton rubrum: a case report. Acta Derm Venereol 2017; 97: 139–140.
Maruyama R, Katoh T, Nishioka K. Demonstration of dermatophyte dissemination from the infected soles using the foot-press method. Mycoses 1998; 41: 145–151.
Yamada T, Yaguchi T, Tamura T, Pich C, Salamin K, Feuermann M, et al. Itraconazole resistance of Trichophyton rubrum mediated by the ABC transporter TruMDR2. Mycoses 2021; 64: 936–946.
Monod M, Feuermann M, Salamin K, Fratti M, Makino M, Alshahni MM, et al. Trichophyton rubrum azole resistance mediated by a new ABC transporter, TruMDR3. Antimicrob Agents Chemother 2019; 63: e00863–e00819.
Yamaguchi H. Potential of ravuconazole and its prodrugs as the new oral therapeutics for onychomycosis. Med Mycol J 2016; 57: E93–E110.
Watanabe S, Tsubouchi I, Okubo A. Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: a multicenter, double-blind, randomized phase III study. J Dermatol 2018; 45: 1151–1159.
Foley K, Gupta AK, Versteeg S, Mays R, Villanueva E, John D. Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev 2020; 1: CD012093.
Saunte DML, Pereiro-Ferreirós M, Rodríguez-Cerdeira C, Sergeev AY, Arabatzis M, Prohić A, et al. Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic. J Eur Acad Dermatol Venereol 2021; 35: 1582–1586.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Hiromitsu Noguchi, Tadahiko Matsumoto, Masataro Hiruma, Utako Kimura, Kayo Kashiwada-Nakamura, Masahide Kubo, Takashi Yaguchi, Satoshi Fukushima, Rui Kano
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
